Molecular and Cellular Research on Rare Lung Diseases
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Molecular and Translational Medicine".
Deadline for manuscript submissions: closed (31 March 2024) | Viewed by 4270
Special Issue Editors
Interests: rare respiratory diseases; immunology of the lung; flow cytometry analysis; lung transplantation; severe asthma; biomarkers
Special Issues, Collections and Topics in MDPI journals
Interests: immunology; flow cytometry; allergy; biomarkers
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Rare lung diseases are associated with high mortality and morbidity and a mean survival of about 5–6 years from the onset of symptoms. They are chronic, irreversible, progressive group of disorders associated with poor prognosis. It is difficult to diagnose due to similar clinical and radiological signs. Very few treatments are now available and lung transplantation is considered the best therapeutic option in end-stage and progressive form of disease. Risk factors can include smoking, genetic predisposition and environmental variables linked to pathological alteration of lung epithelium. The exact pathogenetic mechanisms leading to the development of these disorders are not fully understood. Molecular and cellular research on this field is useful for the study of these diseases since these aspects are fundamental in the pathogenesis and progression of rare lung disease.
Dr. Laura Bergantini
Dr. Miriana d'Alessandro
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- pulmonary fibrosis
- rare lung diseases
- lung transplant
- biomarkers
- bronchoalveolar lavage